Cell line · CVCL_0530
SK-N-MC
Cancer cell line, Homo sapiens. Askin tumor. Cellosaurus records it as misclassified. 61 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. SK-N-MC. Cell lines, record CVCL_0530. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0530
On this page
Cell line
As Cellosaurus gives it.
- Name
- SK-N-MC
- Accession
- CVCL_0530
- RRID
- RRID:CVCL_0530
- Synonyms
- SKNMC, SK-NM-C, SK-NMC
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 12Y
- Category
- Cancer cell line
- Diseases
- Askin tumor (NCIt C7542); Peripheral primitive neuroectodermal tumor (ORDO Orphanet_370348)
- Derived from
- Orbital region (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Misclassified | Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388). |
Source Cellosaurus
Papers61
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Seclidemstat (SP-2577) Induces Transcriptomic Reprogramming and Cytotoxicity in Multiple Fusion-Positive Sarcomas. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer. | Sci Adv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Refined culture conditions with increased physiological relevance uncover oncogene-dependent metabolic signatures in Ewing sarcoma spheroids. | Cell Rep Methods | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Activation of Bradykinin B2 Receptors in Astrocytes Stimulates the Release of Leukemia Inhibitory Factor for Autocrine and Paracrine Signaling. | Int J Mol Sci | 2024 | Its Methods give the RRID and name the line | PubMed | |
| STAG2 loss in Ewing sarcoma alters enhancer-promoter contacts dependent and independent of EWS::FLI1. | EMBO Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer's disease. | Mol Neurodegener | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3. | EBioMedicine | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages. | Cancer Immunol Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors. | Br J Pharmacol | 2024 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 61
See all 61 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | SK-N-MC-IXC | CVCL_1398 | Has a recorded problem | Cell lines |
| Derived from it | SKF5 | CVCL_WY49 | Has a recorded problem | Cell lines |
| Derived from it | SKF6 | CVCL_WY50 | Has a recorded problem | Cell lines |
Cell banks10
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | HTB-10 | ATCC | |
| CLS | 300340 | CLS | |
| CancerTools | 161936 | CancerTools | |
| DSMZ | ACC-203 | DSMZ | |
| ECACC | 90022302 | ECACC | |
| Hysigen | TCH-C333 | Hysigen | |
| IZSLER | BS TCL 93 | Cellosaurus | |
| KCB | KCB 2012033YJ | Cellosaurus | |
| KCLB | 30010 | KCLB | |
| NCBI_Iran | C535 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0530
GET https://conductscience.org/api/cell-lines/v1/CVCL_0530/papers?page=2